Literature DB >> 10184946

Carve outs: definition, experience, and choice among candidate conditions.

D Blumenthal1, M B Buntin.   

Abstract

Despite increasing discussion of carve outs as a device for controlling costs and improving quality of care, little systematic information exists on the effects of carve outs on cost, quality, and access to healthcare services. In the absence of such information, a conceptual framework is useful for deciding which conditions and populations may benefit from carve-out strategies, and how such arrangements should be designed. After carefully defining carve outs, and distinguishing them from other similar arrangements, this paper identifies five characteristics of a healthcare condition that increase the likelihood that a carve out's benefits will outweigh its drawbacks. The paper also examines the advantages and disadvantages of alternative approaches to structuring and administering carve-out arrangements, including how to pay for services, how to integrate them with mainstream care, provisions for consumer choice and provisions for carve-out accountability. The piece concludes that population carve outs, in which all the healthcare problems of a group of patients are managed by the carve-out organization, have inherent advantages, and identifies candidate conditions for population carve outs.

Entities:  

Mesh:

Year:  1998        PMID: 10184946

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  3 in total

1.  Why carve out? Determinants of behavioral health contracting choice among large U.S. employers.

Authors:  D Hodgkin; C M Horgan; D W Garnick; E L Merrick; D Goldin
Journal:  J Behav Health Serv Res       Date:  2000-05       Impact factor: 1.505

2.  Making the case for biotechnology Reinsurance (BIO-RE).

Authors:  Bruce Pyenson
Journal:  Biotechnol Healthc       Date:  2008-11

3.  Carve-out plan financial requirements associated with national behavioral health parity.

Authors:  Sarah Friedman; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Health Serv Res       Date:  2020-09-02       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.